JAK2 and acute myeloid leukemia: At AML transformation, five patients (UPN1-5) had the same CALR, MPL, or JAK2 mutation as that of ET along with new additional mutations: TP53, NRAS, U2AF1, RUNX1, or CEBPA mutation.